Usa covid-19 testing vaccine Usa

COVID-19: Less than 10% of US adult population developed antibodies by July

Reading now: 621
www.medicalnewstoday.com

The Lancet.Many experts consider seroprevalence to be the most comprehensive method of tracking the spread of COVID-19 in communities.

Seroprevalence refers to the percentage of individuals in a population who have antibodies against an infectious agent.Seroprevalence surveys use antibody tests to check blood samples for the presence of antibodies.

In this case, the researchers checked the presence of antibodies against SARS-CoV-2, which is the virus that causes COVID-19. A person who is seropositive usually has measurable levels of antibodies in the blood around 1–3 weeks after contracting the infection.However, seroprevalence studies are challenging, as they require outreach into communities to perform random blood draws, and some people.

Read more on medicalnewstoday.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA